检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:韩芳芳 董昀[1] 朱渊[2] 韩辰燕[1] HAN Fangfang;DONG Yun;ZHU Yuan;HAN Chenyan(Department of Integrated Traditional Chinese and Western Medicine,Shanghai Chest Hospital,Chest Hospital Affiliated to Shanghai Jiaotong University,Shanghai,200030;Nursing Department,Shanghai Chest Hospital,Chest Hospital Affiliated to Shanghai Jiaotong University,Shanghai,200030)
机构地区:[1]上海市胸科医院/上海市交通大学附属胸科医院中西医结合科,上海200030 [2]上海市胸科医院/上海市交通大学附属胸科医院护理部,上海200030
出 处:《实用临床医药杂志》2021年第13期102-105,共4页Journal of Clinical Medicine in Practice
基 金:国家自然科学基金委员会青年科学基金项目(81904114);上海市胸科医院科技发展基金项目(YJHL03);上海交通大学护理学院科研项目(JYHZ2037)。
摘 要:目的观察黄柏红花散对抗肿瘤药物相关静脉炎的预防效果。方法将270例使用抗肿瘤药物患者随机分为3组,A组采用黄柏红花散外敷,B组采用尤卓尔外涂,C组采用尤卓尔涂抹联合黄柏红花散外敷,每组90例。观察3组静脉炎发生率及疼痛发生情况。结果C组静脉炎发生率与疼痛发生率与A组和B组比较,差异均有统计学意义(P<0.05)。结论尤卓尔联合黄柏红花散可有效预防抗肿瘤药物相关静脉炎的发生,且联合用药效果更佳。Objective To observe effect of Huangbai Honghua Powder in preventing phlebitis caused by antitumor drugs.Methods A total of 270 patients using anti-tumor drugs were randomly divided into three groups.A group(n=90)used Huangbai Honghua Powder for external application,B group(n=90)used hydrocortisone butyrate cream for external application,and C group(n=90)used external application of hydrocortisone butyrate cream and Huangbai Honghua Powder.The incidence of phlebitis and the occurrence of pain in the three groups were observed.Results The incidence rates of phlebitis and pain in the group C showed significant differences when compared with those in the groups A and B(P<0.05).Conclusion External application of hydrocortisone butyrate cream and Huangbai Honghua Powder can effectively prevent the occurrence of antitumor drug-related phlebitis,and is higher in safety.
分 类 号:R248[医药卫生—中医临床基础] R735[医药卫生—中医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.226.166.121